Kerry Wentworth

Equibles does not estimate personal net worth.

Get an email with a short summary when Nuvation Bio Inc. publishes a filing, an earnings call transcript or a press release.

Get NUVB alerts

About Kerry Wentworth

Kerry Wentworth has spoken on 1 investor event across 1 company, most recently for Nuvation Bio Inc. on June 12, 2025. Nuvation Bio Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nuvation Bio Inc. includes David Hung (CEO and Board Member), Moses Makunje (CFO and Chief Accounting Officer), Philippe Sauvage (CFO) and 7 others.

Kerry Wentworth on recent calls

“And I'll just add to that that this is how we conducted our clinical trials, and there were no issues.”

Other, Nuvation Bio FDA Approval Conference Call · June 12, 2025

Affiliation history

Nuvation Bio Inc. (NUVB)
Proxy statement

Current
Start not stated–present

Last confirmed April 10, 2026

Company network

Nuvation Bio Inc.

NUVB

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2025-06-12

View calls and events

Leadership on record at Nuvation Bio Inc.

David Hung CEO, Board Member
Moses Makunje CFO, Chief Accounting Officer
Philippe Sauvage CFO
Dr. Junyuan (Jerry) Wang Board Member
Dr. Xiangmin (Min) Cui, Ph.D. Board Member
Kathryn E. Falberg Board Member
Kim Blickenstaff Board Member
Min Cui Board Member
Robert B. Bazemore Board Member
Robert Mashal Board Member

Recent activity

Conference Nuvation Bio FDA Approval Conference Call Nuvation Bio Inc. (NUVB)
2025-06-12